Champions Oncology

Champions Oncology was founded by some of the world’s most renowned specialists in the field of cancer diagnosis, treatment, and research. Our team is comprised of seasoned oncology professionals passionately dedicated to working with you to accelerate oncology drug development, improve outcomes and extend lives. Our core platform, the Champions TumorGraft™ offers an enhanced xenograft mouse avatar model for growing and testing human tumors.
Type
Public
HQ
Hackensack, US
Founded
2007
Size (employees)
57 (est)
Champions Oncology was founded in 2007 and is headquartered in Hackensack, US

Key People at Champions Oncology

Joel Ackerman

Joel Ackerman

CEO
Scott Tobin

Scott Tobin

Director
Ronnie Morris

Ronnie Morris

President
Misti Ushio

Misti Ushio

Involved

Champions Oncology Office Locations

Champions Oncology has offices in Hackensack, London, Baltimore
Hackensack, US
London, GB
Baltimore, US

Champions Oncology Metrics

Champions Oncology Summary

Market capitalization

$36 M

Closing share price

$3.22
Champions Oncology's current market capitalization is $36 M.

Champions Oncology Financials

Champions Oncology's revenue is $11.2 M in FY, 2016 which is 26.16% increase from the previous period.
FY, 2016FY, 2015FY, 2014

Revenue

$11.2 M$8.86 M$11.6 M

Revenue growth, %

26.2%-23.3%

Operating income

$-10.3 M$-13.2 M$-6.26 M

Operating expense total

$21.5 M$22.1 M$17.8 M

Net Income

$-10.4 M$-13.1 M$-7.41 M

Operating cash flow

$-6.77 M$3.47 M$-3.67 M

Champions Oncology Market Value History

We estimate that Champions Oncology's current employees are approximately 20% female and 80% male.

Champions Oncology Online Presence

Champions Oncology Company Life

You may also be interested in